PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis

• Claire B. Pollock,

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Yuzhi Yin,

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Hongyan Yuan,

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Xiao Zeng,

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Sruthi King,

  Affiliation Department of Pharmacology, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Xin Li,

  Affiliation Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Levy Kopelovich,

  Affiliation Chemoprevention Agent Development and Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Chris Albanese,

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯
• Robert I. Glazer

  * E-mail: glazerr@georgetown.edu

  Affiliation Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C., United States of America

  ⨯